Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The most common subcutaneous injection sites are: Abdomen: at or under the level of the belly button, about 1.5 inches away from the navel Upper arm: back or side of the upper arm, about 3 inches above the elbow and 3 inches below the shoulder Upper thigh: front or side of the upper thigh If youre self-administering your subcutaneous injection, this should be done in the abdomen or upper thigh only
You're managing two half-lives, two sets of side effects, two storage requirements, and potential interactions that no tox screen has evaluated
No surprise membership fees hiding the real price of care
At the molecular level, 5-amino-1MQ functions as a competitive inhibitor of NNMT, demonstrating remarkable potency with an IC of 1.2 0.1 M under standard assay conditions (50 M SAM, 100 M nicotinic acid). This represents a dramatic 10-fold improvement over the parent compound 1-methylquinolinium, achieved through strategic amino group substitution that enhances binding affinity to the NNMT active site. The compound's mechanism centers on preventing the methylation of nicotinamide to 1-methylnicotinamide (1-MNA), thereby preserving nicotinamide for recycling back to NAD+ through the salvage pathway. This intervention effectively blocks what researchers have termed the "NNMT metabolic drain" a process that simultaneously depletes NAD+ precursors and consumes cellular methylation capacity
Peptides might be the solution youre looking for
Aod-9604 is not the same as full-length growth hormone
